AB
NAUT icon

Amalgamated Bank’s Nautilus Biotechnolgy NAUT Stock Holding History

Amalgamated Bank’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,654
Closed -$1K – 3091
2025
Q1 		$1K Hold
1,654
– – ﹤0.01% 2921
2024
Q4 		$3K Hold
1,654
– – ﹤0.01% 2859
2024
Q3 		$5K Hold
1,654
– – ﹤0.01% 2764
2024
Q2 		$4K Hold
1,654
– – ﹤0.01% 2867
2024
Q1 		$5K Sell
1,654
-2,785
-63% -$7.9K ﹤0.01% 2723
2023
Q4 		$13K Sell
4,439
-492
-10% -$1.41K ﹤0.01% 2811
2023
Q3 		$16K Hold
4,931
– – ﹤0.01% 2753
2023
Q2 		$19K Hold
4,931
– – ﹤0.01% 2768
2023
Q1 		$14K Sell
4,931
-1,104
-18% -$2.32K ﹤0.01% 2756
2022
Q4 		$11K Hold
6,035
– – ﹤0.01% 2868
2022
Q3 		$13K Hold
6,035
– – ﹤0.01% 2903
2022
Q2 		$16K Buy
+6,035
New +$22.5K ﹤0.01% 2905

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return

Amalgamated Bank's NAUT Position: Q2 2025 in Review

Amalgamated Bank sold out of Nautilus Biotechnolgy (NAUT) in Q2 2025, closing a stake of 1,654 shares — an estimated $1K sold.

Amalgamated Bank first reported a position in NAUT in Q2 2022 and held it in 12 quarters. The position peaked at $19K in Q2 2023. 71 funds tracked by Wall St. Rank hold NAUT as of Q2 2025.

  • Amalgamated Bank reported no remaining Nautilus Biotechnolgy position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 1,654 Nautilus Biotechnolgy shares in Q2 2025, an estimated $1K.
  • Amalgamated Bank first reported a position in Nautilus Biotechnolgy in Q2 2022 and held it in 12 quarters.
  • Amalgamated Bank's Nautilus Biotechnolgy position peaked at $19K in Q2 2023.
  • 71 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.